Selective ERK1/2 agonists isolated from Melia azedarach with potent anti-leukemic activity

Ning Wang(Shanghai Ninth People's Hospital), Yaacov Ben‐David(Health Sciences Centre)
BMC Cancer
August 2, 2019
Cited by 31


Related Papers